Laura Prendergast
Stock Analyst at Stifel
(4.64)
# 177
Out of 5,172 analysts
18
Total ratings
47.06%
Success rate
67.22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Prendergast
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics | Maintains: Buy | $15 → $24 | $19.42 | +23.58% | 2 | Mar 9, 2026 | |
| OLMA Olema Pharmaceuticals | Initiates: Buy | $48 | $14.08 | +240.91% | 1 | Feb 11, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Initiates: Buy | $23 | $8.68 | +164.98% | 1 | Feb 11, 2026 | |
| RVMD Revolution Medicines | Maintains: Buy | $85 → $170 | $95.78 | +77.49% | 4 | Jan 22, 2026 | |
| FHTX Foghorn Therapeutics | Initiates: Buy | $12 | $5.00 | +140.00% | 1 | Dec 4, 2025 | |
| NUVL Nuvalent | Maintains: Buy | $115 → $135 | $94.77 | +42.45% | 2 | Nov 17, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Buy | $8 | $2.11 | +279.15% | 2 | Oct 16, 2025 | |
| ERAS Erasca | Initiates: Buy | $4 | $14.60 | -72.60% | 2 | Oct 16, 2025 | |
| COGT Cogent Biosciences | Initiates: Hold | $16 | $33.38 | -52.07% | 1 | Oct 16, 2025 | |
| NKTX Nkarta | Upgrades: Strong Buy | $16 | $2.14 | +647.66% | 2 | Aug 14, 2024 |
Tango Therapeutics
Mar 9, 2026
Maintains: Buy
Price Target: $15 → $24
Current: $19.42
Upside: +23.58%
Olema Pharmaceuticals
Feb 11, 2026
Initiates: Buy
Price Target: $48
Current: $14.08
Upside: +240.91%
BridgeBio Oncology Therapeutics
Feb 11, 2026
Initiates: Buy
Price Target: $23
Current: $8.68
Upside: +164.98%
Revolution Medicines
Jan 22, 2026
Maintains: Buy
Price Target: $85 → $170
Current: $95.78
Upside: +77.49%
Foghorn Therapeutics
Dec 4, 2025
Initiates: Buy
Price Target: $12
Current: $5.00
Upside: +140.00%
Nuvalent
Nov 17, 2025
Maintains: Buy
Price Target: $115 → $135
Current: $94.77
Upside: +42.45%
Black Diamond Therapeutics
Oct 16, 2025
Reinstates: Buy
Price Target: $8
Current: $2.11
Upside: +279.15%
Erasca
Oct 16, 2025
Initiates: Buy
Price Target: $4
Current: $14.60
Upside: -72.60%
Cogent Biosciences
Oct 16, 2025
Initiates: Hold
Price Target: $16
Current: $33.38
Upside: -52.07%
Nkarta
Aug 14, 2024
Upgrades: Strong Buy
Price Target: $16
Current: $2.14
Upside: +647.66%